Company registration number 05376066 (England and Wales)
EQUIMED EUROPE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
EQUIMED EUROPE LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 4
EQUIMED EUROPE LIMITED
BALANCE SHEET
AS AT 31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
3
3,533
4,416
Current assets
Debtors
852,012
867,780
Cash at bank and in hand
214,646
258,418
1,066,658
1,126,198
Creditors: amounts falling due within one year
(724,800)
(757,946)
Net current assets
341,858
368,252
Net assets
345,391
372,668
Capital and reserves
Called up share capital
4
4
Profit and loss reserves
345,387
372,664
Total equity
345,391
372,668
EQUIMED EUROPE LIMITED
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2024
31 December 2024
- 2 -

For the financial year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges her responsibilities for:

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with section 444 of the Companies Act 2006, all of the members of the company have consented to the preparation of abridged financial statements pursuant to paragraph 1A of Schedule 1 to the Small Companies and Groups (Accounts and Directors’ Report) Regulations (SI 2008/409)(b).

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 10 June 2025
Mrs T S Thomas
Director
Company registration number 05376066 (England and Wales)
EQUIMED EUROPE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -
1
Accounting policies
Company information

Equimed Europe Limited is a private company limited by shares incorporated in England and Wales. The registered office is 2 Hilliards Court, Chester Business Park, Chester, Cheshire, CH4 9PX.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Office Equipment
20% on reducing balance
Motor vehicles
20% on reducing balance
1.3
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
1
1
EQUIMED EUROPE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 4 -
3
Tangible fixed assets
Total
£
Cost
At 1 January 2024 and 31 December 2024
23,557
Depreciation and impairment
At 1 January 2024
19,141
Depreciation charged in the year
883
At 31 December 2024
20,024
Carrying amount
At 31 December 2024
3,533
At 31 December 2023
4,416
2024-12-312024-01-01falsefalsefalse10 June 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityMrs T S ThomasMrs T S Thomas053760662024-01-012024-12-31053760662024-12-31053760662023-12-3105376066core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3105376066core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3105376066core:ShareCapital2024-12-3105376066core:ShareCapital2023-12-3105376066core:RetainedEarningsAccumulatedLosses2024-12-3105376066core:RetainedEarningsAccumulatedLosses2023-12-3105376066bus:CompanySecretaryDirector12024-01-012024-12-3105376066core:FurnitureFittings2024-01-012024-12-3105376066core:MotorVehicles2024-01-012024-12-31053760662023-01-012023-12-31053760662023-12-3105376066bus:PrivateLimitedCompanyLtd2024-01-012024-12-3105376066bus:SmallCompaniesRegimeForAccounts2024-01-012024-12-3105376066bus:FRS1022024-01-012024-12-3105376066bus:AuditExemptWithAccountantsReport2024-01-012024-12-3105376066bus:Director12024-01-012024-12-3105376066bus:CompanySecretary12024-01-012024-12-3105376066bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP